UNITED THERAPEUTICS Corp (UTHR) › Operating Cash FlowUNITED THERAPEUTICS Corp (UTHR) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2008: -$40.43M2009: $99.72M2010: $211.53M2011: $250.19M2012: $323.63M2015: $382.80M2016: $643.60M2017: $474.20M2018: $778.40M2019: -$206.60M2020: $755.70M2021: $598.20M2022: $802.50M2023: $978.00M2024: $1.33B2025: $1.56B$1.56B2008Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$1.56B+17.6%2024$1.33B+35.7%2023$978.00M+21.9%2022$802.50M+34.2%2021$598.20M-20.8%2020$755.70M+465.8%2019-$206.60M-126.5%2018$778.40M+64.2%2017$474.20M-26.3%2016$643.60M+68.1%2015$382.80M—2012$323.63M+29.4%2011$250.19M+18.3%2010$211.53M+112.1%2009$99.72M+346.7%2008-$40.43M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share